Is OS Therapies Stock a Good Investment?
OS Therapies Investment Advice | OSTX |
- Examine OS Therapies' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research OS Therapies' leadership team and their track record. Good management can help OS Therapies navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact OS Therapies' business and its evolving consumer preferences.
- Compare OS Therapies' performance and market position to its competitors. Analyze how OS Therapies is positioned in terms of product offerings, innovation, and market share.
- Check if OS Therapies pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about OS Therapies' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in OS Therapies Incorporated stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if OS Therapies Incorporated is a good investment.
Sell | Buy |
Strong Sell
Market Performance | OK | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine OS Therapies Stock
Researching OS Therapies' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 25.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.32. OS Therapies had not issued any dividends in recent years.
To determine if OS Therapies is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding OS Therapies' research are outlined below:
| OS Therapies is way too risky over 90 days horizon | |
| OS Therapies appears to be risky and price may revert if volatility continues | |
| OS Therapies has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.79 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OS Therapies generates negative cash flow from operations | |
| OS Therapies has a frail financial position based on the latest SEC disclosures | |
| About 25.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: OS Therapies to Attend the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire |
OS Therapies Target Price Consensus
OSTX target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. OS Therapies' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Strong Buy |
Most OSTX analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand OSTX stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of OS Therapies, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationOS Therapies Target Price Projection
OS Therapies' current and average target prices are 4.16 and 15.00, respectively. The current price of OS Therapies is the price at which OS Therapies Incorporated is currently trading. On the other hand, OS Therapies' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On OS Therapies Target Price
OS Therapies Analyst Ratings
OS Therapies' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about OS Therapies stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of OS Therapies' financials, market performance, and future outlook by experienced professionals. OS Therapies' historical ratings below, therefore, can serve as a valuable tool for investors.OS Therapies' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 74.14 M.Market Cap |
|
OS Therapies' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (11.23) | (11.79) | |
| Return On Capital Employed | 0.21 | 0.20 | |
| Return On Assets | (11.23) | (11.79) | |
| Return On Equity | 0.29 | 0.26 |
Determining OS Therapies' profitability involves analyzing its financial statements and using various financial metrics to determine if OS Therapies is a good buy. For example, gross profit margin measures OS Therapies' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of OS Therapies' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in OS Therapies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of OS Therapies Incorporated. Check OS Therapies' Beneish M Score to see the likelihood of OS Therapies' management manipulating its earnings.
Basic technical analysis of OSTX Stock
As of the 15th of January 2025, OS Therapies owns the standard deviation of 11.26, and Market Risk Adjusted Performance of (0.45). In connection with fundamental indicators, the technical analysis model allows you to check timely technical drivers of OS Therapies, as well as the relationship between them.OS Therapies' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OS Therapies insiders, such as employees or executives, is commonly permitted as long as it does not rely on OS Therapies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases OS Therapies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mckean-dieser Avril Suzette over two months ago Insider Trading | ||
Mckean-dieser Avril Suzette over two months ago Insider Trading | ||
Ciccio John over three months ago Acquisition by Ciccio John of 266306 shares of OS THERAPIES at 75000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 30264 shares of OS THERAPIES at 50000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 101765 shares of OS THERAPIES at 25000.0 subject to Rule 16b-3 | ||
Search Theodore F. over three months ago Acquisition by Search Theodore F. of 30264 shares of OS THERAPIES at 50000.0 subject to Rule 16b-3 | ||
Ciccio John over three months ago Acquisition by Ciccio John of 101765 shares of OS THERAPIES at 25000.0 subject to Rule 16b-3 | ||
Acevedo Christopher P. over three months ago Disposition of tradable shares by Acevedo Christopher P. of OS THERAPIES subject to Rule 16b-3 |
Understand OS Therapies' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing OS Therapies' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0941 | |||
| Market Risk Adjusted Performance | (0.45) | |||
| Mean Deviation | 6.76 | |||
| Semi Deviation | 7.2 | |||
| Downside Deviation | 8.5 | |||
| Coefficient Of Variation | 964.78 | |||
| Standard Deviation | 11.26 | |||
| Variance | 126.79 | |||
| Information Ratio | 0.104 | |||
| Jensen Alpha | 1.12 | |||
| Total Risk Alpha | 1.36 | |||
| Sortino Ratio | 0.1378 | |||
| Treynor Ratio | (0.46) | |||
| Maximum Drawdown | 79.09 | |||
| Value At Risk | (12.70) | |||
| Potential Upside | 21.53 | |||
| Downside Variance | 72.29 | |||
| Semi Variance | 51.8 | |||
| Expected Short fall | (8.01) | |||
| Skewness | 1.51 | |||
| Kurtosis | 5.87 |
| Risk Adjusted Performance | 0.0941 | |||
| Market Risk Adjusted Performance | (0.45) | |||
| Mean Deviation | 6.76 | |||
| Semi Deviation | 7.2 | |||
| Downside Deviation | 8.5 | |||
| Coefficient Of Variation | 964.78 | |||
| Standard Deviation | 11.26 | |||
| Variance | 126.79 | |||
| Information Ratio | 0.104 | |||
| Jensen Alpha | 1.12 | |||
| Total Risk Alpha | 1.36 | |||
| Sortino Ratio | 0.1378 | |||
| Treynor Ratio | (0.46) | |||
| Maximum Drawdown | 79.09 | |||
| Value At Risk | (12.70) | |||
| Potential Upside | 21.53 | |||
| Downside Variance | 72.29 | |||
| Semi Variance | 51.8 | |||
| Expected Short fall | (8.01) | |||
| Skewness | 1.51 | |||
| Kurtosis | 5.87 |
Consider OS Therapies' intraday indicators
OS Therapies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OS Therapies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 7252.45 | |||
| Daily Balance Of Power | (0.70) | |||
| Rate Of Daily Change | 0.89 | |||
| Day Median Price | 4.35 | |||
| Day Typical Price | 4.29 | |||
| Price Action Indicator | (0.44) | |||
| Period Momentum Indicator | (0.49) |
OS Therapies Corporate Filings
8K | 14th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 13th of January 2025 Other Reports | ViewVerify | |
| 27th of November 2024 Other Reports | ViewVerify | |
10Q | 15th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
OSTX Stock media impact
Far too much social signal, news, headlines, and media speculation about OS Therapies that are available to investors today. That information is available publicly through OSTX media outlets and privately through word of mouth or via OSTX internal channels. However, regardless of the origin, that massive amount of OSTX data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of OS Therapies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of OS Therapies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to OS Therapies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive OS Therapies alpha.
OS Therapies Corporate Management
| Jack Doll | Chief Staff | Profile | |
| Robert Petit | Chief Officer | Profile | |
| Christopher Acevedo | Chief Officer | Profile | |
| Gerald Commissiong | Chief Officer | Profile |
Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.